Skip to main content

Table 1 Baseline characteristics for the 23 patients

From: Analysis of differences between 99mTc-MAA SPECT- and 90Y-microsphere PET-based dosimetry for hepatocellular carcinoma selective internal radiation therapy

Clinical variable

Value

Age (years)

63 ± 9

Sex (n)

 Male

21

 Female

2

Child-Pugh class* (n)

 A5

19

 A6

2

 B7

1

BCLC stage (n)

 B

2

 C

21

Prior local therapy** (n)

 Yes

6

 No

17

Tumor morphology (n)

 Infiltrative

15

 Nodular

8

Portal vein thrombosis (n)

 Yes

20

 No

3

Total tumor volume (mL)***

 Mean ± SD

437 ± 344

 Median [range]

353 [58–1250]

Liver tumor involvement (n)

 < 25%

15

 25–50%

8

Treatment (n + 1)

 Whole liver

1

 Lobar

17

 Sectorial

4

 Segmental

2

  1. WHO World Health Organization, BCLC Barcelona Clinic Liver Cancer
  2. *One patient was non-cirrhotic
  3. **Prior local therapies include chemoembolization and radiofrequency ablation
  4. ***Number of lesions was 1 for all treatments except one treatment that concerned 2 lesions